Evaluation of a Digital Therapy of Auditory Training — AUDISSEE  

Hearing Loss, Age-Related Clinical Trial

Official title: AUDISSEE-Evaluation of a New Digital Therapy of a Cognitive Auditory Training

Status Not yet recruiting

Clinical Trial Summary

The aim of the study is to evaluate the efficiency of the medical device AUDISSEE in improving the perception in noise ability of presbycusis patients with hearing-aids.

Clinical Trial Description

AUDISSEE is a digital therapy designed specifically to improve the hearing in noise of presbycusis patients by offering a complete cognitive auditory training, with verbal and non-verbal (especially musical) stimuli. This therapy is designed improve the comfort of life of people fitted with hearing aids by improving the observance of the wearing of their hearing aids. It is designed for the greatest number of people regardless of age or type of hearing aids and adapts to all levels of hearing loss (mild to severe). In this study, 240 patients will be randomized in four groups. The first group will be trained with AUDISSEE-verbal, AUDISSE-non-verbal then with the placebo therapy. The second group will be trained with AUDISSEE-non-verbal, AUDISSEE-verbal, then with the placebo therapy. The third group will be trained with the placebo therapy then AUDISSEE-verbal, and AUDISSE-non-verbal. The fourth group will be trained with the placebo therapy then AUDISSEE-non-verbal, and AUDISSE-verbal. Each training session will last 20 minutes. 3 sessions are planned per week, for 5 weeks for each sub-training. The protocol lasts 20 weeks in total for each patient. ;

Related Conditions & MeSH terms

• Hearing Loss
• Hearing Loss, Age-Related
• Presbycusis

• NCT number: NCT05848661
• Study type: Interventional
• Source: Humans Matter
• Contact: agathe pralus, PhD
• Phone: +33611828004
• Email: a.pralus@humansmatter.co
• Status: Not yet recruiting
• Phase: N/A
• Start date: September 2024
• Completion date: March 2025